Deals

The latest pharma deals — mergers, acquisitions, licensing agreements, and partnerships shaping the business of drug development worldwide.

Cellares founders
Manufacturing

Cellares, GenomeFrontier to evaluate CAR-T therapy production

Cellares and Taiwan's GenomeFrontier have linked to assess the IDMO's Cell Shuttle platform for use in the production of virus-free CAR-T therapies.
Joseph Keenan Sep 16, 2026 2:02pm
Teva
Favicon Fierce Biotech

Teva saddles up as bidder for bankrupt BioXcel’s CNS assets

Aug 28, 2026 9:17am
Room

‘No discussions’ ongoing for AstraZeneca-BMS merger: Reuters

Aug 5, 2026 10:12am
blocks coins money

Editor’s Corner: Why an AZ-BMS merger would be a very bad idea

Aug 3, 2026 12:25am
Belen Garijo Sanofi Merck KGaA
Favicon Fierce Biotech

Sanofi CEO ‘looking deeply’ at pipeline as clearout continues

Jul 30, 2026 3:27am
AstraZeneca

AstraZeneca buys lung cancer drug Zegfrovy from Dizal for $1.5B

Jul 14, 2026 9:57am